首页 > 最新文献

Current Pharmacology Reports最新文献

英文 中文
The Impact of Coenzyme Q10 on Neurodegeneration: a Comprehensive Review 辅酶Q10对神经退行性疾病的影响:一项综合综述
Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-06 DOI: 10.1007/s40495-021-00273-6
Monika Kadian, G. Sharma, S. Pandita, Kritika Sharma, Kanishka Shrivasatava, N. Saini, Ashok Kumar
{"title":"The Impact of Coenzyme Q10 on Neurodegeneration: a Comprehensive Review","authors":"Monika Kadian, G. Sharma, S. Pandita, Kritika Sharma, Kanishka Shrivasatava, N. Saini, Ashok Kumar","doi":"10.1007/s40495-021-00273-6","DOIUrl":"https://doi.org/10.1007/s40495-021-00273-6","url":null,"abstract":"","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"8 1","pages":"1 - 19"},"PeriodicalIF":0.0,"publicationDate":"2022-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52806144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Endophthalmitis: Types and Recent Trends in Diagnosis 眼内炎:类型和诊断的最新趋势
Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-05 DOI: 10.1007/s40495-021-00278-1
Suryanarayan Sharma, R. Bansal, Sunil Kumar
{"title":"Endophthalmitis: Types and Recent Trends in Diagnosis","authors":"Suryanarayan Sharma, R. Bansal, Sunil Kumar","doi":"10.1007/s40495-021-00278-1","DOIUrl":"https://doi.org/10.1007/s40495-021-00278-1","url":null,"abstract":"","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"8 1","pages":"106 - 111"},"PeriodicalIF":0.0,"publicationDate":"2022-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42174028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Green Synthesis-Mediated Nanoparticles and Their Curative Character Against Post COVID-19 Skin Diseases. 绿色合成介导的纳米颗粒及其对COVID-19后皮肤病的治疗作用
Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 Epub Date: 2022-09-09 DOI: 10.1007/s40495-022-00303-x
Nivedhitha Kabeerdass, Selvankumar Thangaswamy, Vaithilingam Mohanasrinivasan, Chandrasekaran Rajasekaran, Selvakumar Sundaram, Thajuddin Nooruddin, Maghimaa Mathanmohun

Purpose of review: This article provides the explanatory manuscript regarding the SARS-Corona virus 2. Sub-titled as the history of single-stranded RNA, internal characters of COVID-19, resource, the life cycle of COVID-19, reservoir of the disease, secondary infections of COVID-19 and nano herbal remedy.

Recent findings: The skin is not the main target of the SARS-corona virus 2 infections but somehow directly or indirectly, it causes exacerbating eruptions on the skin. Recent research shows that curcumin-mediated synthesized AgNPs show its potential character in the entry of respiratory syncytial virus (RSV), blocks interaction with the viral surface, and damages the viral protein. In modern days, molecular docking studies fabricated copper iodide flower extract (CuI-FE) which shows tough inhibitory action against COVID-19. Many articles show green synthesis-mediated nanoparticles like silver, gold, zinc, copper, iron, titanium dioxide, selenium, and cadmium which possess high anti-viricidal activity.

Summary: The anti-oxidant, anti-viral, anti-inflammatory, anti-hive rich plant-mediated nanoparticle synthesis might be an alternative betterment, cost-effective, and eco-friendly medication for the skin disease caused by SARS-corona virus 2 (the viral clinical signs are itchy, hives, rashes, papules, psoriasis, and inflammation) and (non-viral clinical signs-pressure urticaria, contact dermatitis, and acne) that occurred as the result of COVID-19.

综述目的:本文提供了关于sars -冠状病毒2的解释性稿件。副标题为:单链RNA的历史、COVID-19的内部特征、资源、COVID-19的生命周期、疾病库、COVID-19的继发感染和纳米草药。最近的研究发现:皮肤不是sars冠状病毒感染的主要目标,但它会以某种方式直接或间接地加剧皮肤上的皮疹。最近的研究表明,姜黄素介导的AgNPs在呼吸道合胞病毒(RSV)的侵入中显示出潜在的特性,阻断与病毒表面的相互作用,破坏病毒蛋白。近年来,通过分子对接研究,制备出了对COVID-19具有较强抑制作用的碘化铜花提取物(CuI-FE)。许多文章表明,绿色合成介导的纳米颗粒如银、金、锌、铜、铁、二氧化钛、硒和镉具有很高的抗病毒活性。摘要:抗氧化、抗病毒、抗炎、富含抗蜂群的植物介导的纳米颗粒合成可能是治疗由sars -冠状病毒2型引起的皮肤病(病毒性临床症状为瘙痒、荨麻疹、皮疹、丘疹、牛皮癣和炎症)和由COVID-19引起的(非病毒性临床症状为压力性荨麻疹、接触性皮炎和痤疮)的另一种改善、经济、环保的药物。
{"title":"Green Synthesis-Mediated Nanoparticles and Their Curative Character Against Post COVID-19 Skin Diseases.","authors":"Nivedhitha Kabeerdass,&nbsp;Selvankumar Thangaswamy,&nbsp;Vaithilingam Mohanasrinivasan,&nbsp;Chandrasekaran Rajasekaran,&nbsp;Selvakumar Sundaram,&nbsp;Thajuddin Nooruddin,&nbsp;Maghimaa Mathanmohun","doi":"10.1007/s40495-022-00303-x","DOIUrl":"https://doi.org/10.1007/s40495-022-00303-x","url":null,"abstract":"<p><strong>Purpose of review: </strong>This article provides the explanatory manuscript regarding the SARS-Corona virus 2. Sub-titled as the history of single-stranded RNA, internal characters of COVID-19, resource, the life cycle of COVID-19, reservoir of the disease, secondary infections of COVID-19 and nano herbal remedy.</p><p><strong>Recent findings: </strong>The skin is not the main target of the SARS-corona virus 2 infections but somehow directly or indirectly, it causes exacerbating eruptions on the skin. Recent research shows that curcumin-mediated synthesized AgNPs show its potential character in the entry of respiratory syncytial virus (RSV), blocks interaction with the viral surface, and damages the viral protein. In modern days, molecular docking studies fabricated copper iodide flower extract (CuI-FE) which shows tough inhibitory action against COVID-19. Many articles show green synthesis-mediated nanoparticles like silver, gold, zinc, copper, iron, titanium dioxide, selenium, and cadmium which possess high anti-viricidal activity.</p><p><strong>Summary: </strong>The anti-oxidant, anti-viral, anti-inflammatory, anti-hive rich plant-mediated nanoparticle synthesis might be an alternative betterment, cost-effective, and eco-friendly medication for the skin disease caused by SARS-corona virus 2 (the viral clinical signs are itchy, hives, rashes, papules, psoriasis, and inflammation) and (non-viral clinical signs-pressure urticaria, contact dermatitis, and acne) that occurred as the result of COVID-19.</p>","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"8 6","pages":"409-417"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40357656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Nutritional Aspects of People Living with HIV (PLHIV) Amidst COVID-19 Pandemic: an Insight. 艾滋病毒感染者(PLHIV)在 COVID-19 大流行中的营养问题:透视。
Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 Epub Date: 2022-08-06 DOI: 10.1007/s40495-022-00301-z
Fathima A S, Maxima Madhu, V Udaya Kumar, Sameer Dhingra, Nitesh Kumar, Sanjiv Singh, V Ravichandiran, Krishna Murti

Purpose of review: This review elaborates the role of malnutrition in PLHIV (people living with HIV) in the context of COVID-19 and emphasis the need of supplementation, dietary intervention, and nutritional counselling in the post-COVID era. One of the most critical challenges among HIV/AIDS patients is malnutrition since it weakens the immune system and increases risk to opportunistic infections. In HIV (human immunodeficiency virus) infection, weight loss is prevalent due to reduced nutritional consumption, malabsorption, abnormal metabolism, and antiretroviral therapy. Sufficient nutrition is required for optimal immune function, as a result, food therapy is now considered an important adjuvant in the treatment of HIV patients.

Recent findings: Nutritional intervention, such as the use of dietary supplements, can help to prevent nutrient deficiency, lowering the death risk among malnourished HIV population. Immunocompromised individuals are at very high risk for COVID-19 and malnutrition increases the risk of infection by multiple folds. Interventions, such as nutrition education and counselling are important, to improve the condition of HIV Patients by optimising their nutritional status.

Summary: A balanced diet should be one of the most important priorities in preventing PLHIV against the potentially deadly consequences of COVID-19. It is to be ensured that HIV-positive persons continue to get enough and appropriate assistance, such as nutrition and psychological counselling, in the context of COVID-19 infection. The use of telemedicine to maintain nutritional intervention can be beneficial. To meet their nutritional needs and minimise future difficulties, PLHIV infected with COVID-19 should get specialised nutritional education and counselling.

Graphical abstract:

综述目的:本综述在 COVID-19 的背景下阐述了营养不良在 PLHIV(艾滋病病毒感染者)中的作用,并强调在后 COVID 时代需要补充营养、进行膳食干预和提供营养咨询。营养不良是艾滋病毒/艾滋病患者面临的最严峻挑战之一,因为它会削弱免疫系统,增加机会性感染的风险。在艾滋病毒(人体免疫缺陷病毒)感染者中,由于营养消耗减少、吸收不良、新陈代谢异常和抗逆转录病毒治疗,体重普遍下降。充足的营养是实现最佳免疫功能的必要条件,因此,食物疗法现在被认为是治疗艾滋病患者的重要辅助手段:营养干预,如使用膳食补充剂,有助于预防营养缺乏,降低营养不良的艾滋病患者的死亡风险。免疫力低下者感染 COVID-19 的风险非常高,营养不良会使感染风险增加数倍。营养教育和咨询等干预措施对于通过优化 HIV 患者的营养状况来改善他们的病情非常重要。在感染 COVID-19 的情况下,应确保艾滋病毒抗体阳性者继续获得足够和适当的援助,如营养和心理咨询。使用远程医疗来维持营养干预是有益的。为了满足他们的营养需求并尽量减少未来的困难,感染 COVID-19 的艾滋病毒携带者应接受专门的营养教育和咨询:
{"title":"Nutritional Aspects of People Living with HIV (PLHIV) Amidst COVID-19 Pandemic: an Insight.","authors":"Fathima A S, Maxima Madhu, V Udaya Kumar, Sameer Dhingra, Nitesh Kumar, Sanjiv Singh, V Ravichandiran, Krishna Murti","doi":"10.1007/s40495-022-00301-z","DOIUrl":"10.1007/s40495-022-00301-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review elaborates the role of malnutrition in PLHIV (people living with HIV) in the context of COVID-19 and emphasis the need of supplementation, dietary intervention, and nutritional counselling in the post-COVID era. One of the most critical challenges among HIV/AIDS patients is malnutrition since it weakens the immune system and increases risk to opportunistic infections. In HIV (human immunodeficiency virus) infection, weight loss is prevalent due to reduced nutritional consumption, malabsorption, abnormal metabolism, and antiretroviral therapy. Sufficient nutrition is required for optimal immune function, as a result, food therapy is now considered an important adjuvant in the treatment of HIV patients.</p><p><strong>Recent findings: </strong>Nutritional intervention, such as the use of dietary supplements, can help to prevent nutrient deficiency, lowering the death risk among malnourished HIV population. Immunocompromised individuals are at very high risk for COVID-19 and malnutrition increases the risk of infection by multiple folds. Interventions, such as nutrition education and counselling are important, to improve the condition of HIV Patients by optimising their nutritional status.</p><p><strong>Summary: </strong>A balanced diet should be one of the most important priorities in preventing PLHIV against the potentially deadly consequences of COVID-19. It is to be ensured that HIV-positive persons continue to get enough and appropriate assistance, such as nutrition and psychological counselling, in the context of COVID-19 infection. The use of telemedicine to maintain nutritional intervention can be beneficial. To meet their nutritional needs and minimise future difficulties, PLHIV infected with COVID-19 should get specialised nutritional education and counselling.</p><p><strong>Graphical abstract: </strong></p>","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"8 5","pages":"350-364"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40697410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach. 甲基黄嘌呤作为 SARS-CoV-2 的潜在抑制剂:一种硅学方法。
Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 Epub Date: 2022-03-08 DOI: 10.1007/s40495-021-00276-3
Rajan Rolta, Deeksha Salaria, Bhanu Sharma, Oladoja Awofisayo, Olatomide A Fadare, Sonum Sharma, Chirag N Patel, Vikas Kumar, Anuradha Sourirajan, David J Baumler, Kamal Dev

The aim of the present study was to test the binding affinity of methylxanthines (caffeine/theine, methylxanthine, theobromine, theophylline and xanthine) to three potential target proteins namely Spike protein (6LZG), main protease (6LU7) and nucleocapsid protein N-terminal RNA binding domain (6M3M) of SARS-CoV-2. Proteins and ligand were generated using AutoDock 1.5.6 software. Binding affinity of methylxanthines with SARS-CoV-2 target proteins was determined using Autodock Vina. MD simulation of the best interacting complexes was performed using GROMACS 2018.3 (in duplicate) and Desmond program version 2.0 (academic version) (in triplicate) to study the stabile interaction of protein-ligand complexes. Among the selected methylxanthines, theophylline showed the best binding affinity with all the three targets of SARS-CoV-2 (6LZG - 5.7 kcal mol-1, 6LU7 - 6.5 kcal mol-1, 6M3M - 5.8 kcal mol-1). MD simulation results of 100 ns (in triplicate) showed that theophylline is stable in the binding pockets of all the selected SARS-CoV-2 proteins. Moreover, methylxanthines are safer and less toxic as shown by high LD50 value with Protox II software as compared to drug chloroquine. This research supports the use of methylxanthines as a SARS-CoV-2 inhibitor. It also lays the groundwork for future studies and could aid in the development of a treatment for SARS-CoV-2 and related viral infections.

Graphical abstract:

Supplementary information: The online version contains supplementary material available at 10.1007/s40495-021-00276-3.

本研究的目的是测试甲基黄嘌呤(咖啡因/茶碱、甲基黄嘌呤、可可碱、茶碱和黄嘌呤)与SARS-CoV-2的三种潜在靶蛋白,即尖峰蛋白(6LZG)、主要蛋白酶(6LU7)和核帽蛋白N-末端RNA结合域(6M3M)的结合亲和力。蛋白质和配体使用 AutoDock 1.5.6 软件生成。使用 Autodock Vina 测定甲基黄嘌呤与 SARS-CoV-2 目标蛋白的结合亲和力。使用GROMACS 2018.3(一式二份)和Desmond程序2.0版(学术版)(一式三份)对最佳相互作用复合物进行了MD模拟,以研究蛋白质-配体复合物的稳定相互作用。在所选的甲基黄嘌呤中,茶碱与SARS-CoV-2的三个靶标均表现出最佳的结合亲和力(6LZG - 5.7 kcal mol-1,6LU7 - 6.5 kcal mol-1,6M3M - 5.8 kcal mol-1)。100 ns(一式三份)的 MD 模拟结果表明,茶碱在所有选定的 SARS-CoV-2 蛋白的结合口袋中都很稳定。此外,与药物氯喹相比,甲基黄嘌呤在Protox II软件中的半数致死剂量(LD50)值较高,表明甲基黄嘌呤更安全、毒性更低。这项研究支持使用甲基黄嘌呤作为 SARS-CoV-2 抑制剂。它还为今后的研究奠定了基础,有助于开发治疗 SARS-CoV-2 和相关病毒感染的方法:在线版本包含补充材料,可查阅 10.1007/s40495-021-00276-3。
{"title":"Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach.","authors":"Rajan Rolta, Deeksha Salaria, Bhanu Sharma, Oladoja Awofisayo, Olatomide A Fadare, Sonum Sharma, Chirag N Patel, Vikas Kumar, Anuradha Sourirajan, David J Baumler, Kamal Dev","doi":"10.1007/s40495-021-00276-3","DOIUrl":"https://doi.org/10.1007/s40495-021-00276-3","url":null,"abstract":"<p><p>The aim of the present study was to test the binding affinity of methylxanthines (caffeine/theine, methylxanthine, theobromine, theophylline and xanthine) to three potential target proteins namely Spike protein (6LZG), main protease (6LU7) and nucleocapsid protein N-terminal RNA binding domain (6M3M) of SARS-CoV-2. Proteins and ligand were generated using AutoDock 1.5.6 software. Binding affinity of methylxanthines with SARS-CoV-2 target proteins was determined using Autodock Vina. MD simulation of the best interacting complexes was performed using GROMACS 2018.3 (in duplicate) and Desmond program version 2.0 (academic version) (in triplicate) to study the stabile interaction of protein-ligand complexes. Among the selected methylxanthines, theophylline showed the best binding affinity with all the three targets of SARS-CoV-2 (6LZG - 5.7 kcal mol<sup>-1</sup>, 6LU7 - 6.5 kcal mol<sup>-1</sup>, 6M3M - 5.8 kcal mol<sup>-1</sup>). MD simulation results of 100 ns (in triplicate) showed that theophylline is stable in the binding pockets of all the selected SARS-CoV-2 proteins. Moreover, methylxanthines are safer and less toxic as shown by high LD<sub>50</sub> value with Protox II software as compared to drug chloroquine. This research supports the use of methylxanthines as a SARS-CoV-2 inhibitor. It also lays the groundwork for future studies and could aid in the development of a treatment for SARS-CoV-2 and related viral infections.</p><p><strong>Graphical abstract: </strong></p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s40495-021-00276-3.</p>","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"8 2","pages":"149-170"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142085940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of COVID-19 on Antimicrobial Resistance in Paediatric Population: a Narrative Review. COVID-19对儿科人群抗微生物药物耐药性的影响:叙述性综述
Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 Epub Date: 2022-06-28 DOI: 10.1007/s40495-022-00298-5
Arya Karun, Rimple Jeet Kaur, Jaykaran Charan, Krishna Murti, M Ramesh, V Ravichandiran, Sameer Dhingra

Purpose of review: Irrational use of antimicrobials has been reported in paediatric population during the COVID-19 time period. This may lead to potential development of antimicrobial resistance and increased morbidity and mortality among this vulnerable population. The purpose of this review is to ascertain the impact of COVID-19 pandemic on antimicrobial resistance among paediatrics and the possible strategies to minimize the menace of antimicrobial resistance.

Recent findings: Recent findings indicate that the COVID-19 pandemic has direct as well as indirect impact on the development of antimicrobial resistance among paediatric population.

Summary: This review article shows the impact of COVID-19 on the development of antimicrobial resistance and strategies to prevent it with special reference to antimicrobial stewardship programmes among paediatric population.

回顾目的:在2019冠状病毒病疫情期间,已有儿科人群不合理使用抗微生物药物的报告。这可能导致潜在的抗菌素耐药性发展,并增加这一脆弱人群的发病率和死亡率。本综述的目的是确定COVID-19大流行对儿科抗菌素耐药性的影响,以及尽可能减少抗菌素耐药性威胁的可能策略。最近的调查结果:最近的调查结果表明,COVID-19大流行对儿科人群抗菌素耐药性的发展具有直接和间接的影响。摘要:这篇综述文章展示了COVID-19对抗菌素耐药性发展的影响和预防策略,特别提到了儿科人群的抗菌素管理规划。
{"title":"Impact of COVID-19 on Antimicrobial Resistance in Paediatric Population: a Narrative Review.","authors":"Arya Karun,&nbsp;Rimple Jeet Kaur,&nbsp;Jaykaran Charan,&nbsp;Krishna Murti,&nbsp;M Ramesh,&nbsp;V Ravichandiran,&nbsp;Sameer Dhingra","doi":"10.1007/s40495-022-00298-5","DOIUrl":"https://doi.org/10.1007/s40495-022-00298-5","url":null,"abstract":"<p><strong>Purpose of review: </strong>Irrational use of antimicrobials has been reported in paediatric population during the COVID-19 time period. This may lead to potential development of antimicrobial resistance and increased morbidity and mortality among this vulnerable population. The purpose of this review is to ascertain the impact of COVID-19 pandemic on antimicrobial resistance among paediatrics and the possible strategies to minimize the menace of antimicrobial resistance.</p><p><strong>Recent findings: </strong>Recent findings indicate that the COVID-19 pandemic has direct as well as indirect impact on the development of antimicrobial resistance among paediatric population.</p><p><strong>Summary: </strong>This review article shows the impact of COVID-19 on the development of antimicrobial resistance and strategies to prevent it with special reference to antimicrobial stewardship programmes among paediatric population.</p>","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"8 5","pages":"365-375"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244284/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40564504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Myricetin: a Multifunctional Flavonol in Biomedicine. 杨梅素:生物医学中的多功能黄酮醇。
Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 Epub Date: 2022-01-10 DOI: 10.1007/s40495-021-00269-2
Gopikrishna Agraharam, Agnishwar Girigoswami, Koyeli Girigoswami

Purpose of reveiw: The root cause of many diseases like CVD, cancer, and aging is free radicals which exert their effect by interfering with different metabolic pathways. The sources of free radicals can be exogenous, like UV rays from sunlight, and endogenous due to different metabolic by-products.In our body, there are defense mechanisms present, such as antioxidant enzymes and antioxidant molecules to combat these free radicals, but if there is an overload of these free radicals in our body, the defense system may not be sufficient to neutralize these free radicals. In such situations, we are exposed to a chronic low dose of oxidants creating oxidative stress, which is responsible for eliciting different diseases.

Recent findings: Pubmed and Google Scholar are the search engines used to sort out relevant papers on myricetin and its role in combating many diseases. Myricetin is present in many fruits and vegetables and is a known antioxidant. It can elevate the antioxidant enzyme levels; reduces the lipid peroxidation; and is known to protect against cancer. In the case of myocardial dysfunction, myricetin has been shown to suppress the inflammatory cytokines and reduced the mortality rate. Myricetin has also been found to reduce platelet aggregation and control the viral infections by interfering in the DNA replication pathways.

Summary: In this paper, we have briefly reviewed about the different type and site of free radicals and the role of myricetin in addressing the ROS and different diseases.

综述目的:自由基是许多疾病如心血管疾病、癌症、衰老的根本原因,自由基通过干扰不同的代谢途径发挥作用。自由基的来源可以是外源性的,比如来自阳光的紫外线,也可以是内源性的,因为不同的代谢副产物。在我们的身体中,存在防御机制,例如抗氧化酶和抗氧化分子来对抗这些自由基,但如果我们体内这些自由基过载,防御系统可能不足以中和这些自由基。在这种情况下,我们暴露在慢性低剂量的氧化剂中,产生氧化应激,这是引发不同疾病的原因。最近的发现:Pubmed和Google Scholar是用来整理杨梅素及其在对抗许多疾病中的作用的相关论文的搜索引擎。杨梅素存在于许多水果和蔬菜中,是一种已知的抗氧化剂。能提高抗氧化酶水平;减少脂质过氧化;并且可以预防癌症。在心肌功能障碍的情况下,杨梅素已被证明可以抑制炎症细胞因子并降低死亡率。杨梅素也被发现通过干扰DNA复制途径来减少血小板聚集和控制病毒感染。摘要:本文就杨梅素在活性氧和不同疾病中的作用、自由基的类型和部位等方面的研究进展作一综述。
{"title":"Myricetin: a Multifunctional Flavonol in Biomedicine.","authors":"Gopikrishna Agraharam,&nbsp;Agnishwar Girigoswami,&nbsp;Koyeli Girigoswami","doi":"10.1007/s40495-021-00269-2","DOIUrl":"https://doi.org/10.1007/s40495-021-00269-2","url":null,"abstract":"<p><strong>Purpose of reveiw: </strong>The root cause of many diseases like CVD, cancer, and aging is free radicals which exert their effect by interfering with different metabolic pathways. The sources of free radicals can be exogenous, like UV rays from sunlight, and endogenous due to different metabolic by-products.In our body, there are defense mechanisms present, such as antioxidant enzymes and antioxidant molecules to combat these free radicals, but if there is an overload of these free radicals in our body, the defense system may not be sufficient to neutralize these free radicals. In such situations, we are exposed to a chronic low dose of oxidants creating oxidative stress, which is responsible for eliciting different diseases.</p><p><strong>Recent findings: </strong>Pubmed and Google Scholar are the search engines used to sort out relevant papers on myricetin and its role in combating many diseases. Myricetin is present in many fruits and vegetables and is a known antioxidant. It can elevate the antioxidant enzyme levels; reduces the lipid peroxidation; and is known to protect against cancer. In the case of myocardial dysfunction, myricetin has been shown to suppress the inflammatory cytokines and reduced the mortality rate. Myricetin has also been found to reduce platelet aggregation and control the viral infections by interfering in the DNA replication pathways.</p><p><strong>Summary: </strong>In this paper, we have briefly reviewed about the different type and site of free radicals and the role of myricetin in addressing the ROS and different diseases.</p>","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"8 1","pages":"48-61"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39687674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 30
Lefamulin: a New Hope in the Field of Community-Acquired Bacterial Pneumonia. 利福霉素:社区获得性细菌性肺炎领域的新希望。
Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 Epub Date: 2022-07-06 DOI: 10.1007/s40495-022-00297-6
Shubham Adhikary, Meher Kaur Duggal, Saraswathy Nagendran, Meena Chintamaneni, Hardeep Singh Tuli, Ginpreet Kaur

Purpose of review: Community-acquired bacterial pneumonia (CABP) continues to be a worldwide health concern since it is the major cause of mortality and hospitalisation worldwide. Increased macrolide resistance among Streptococcus pneumoniae and other infections has resulted in a significantly larger illness burden, which has been exacerbated by evolving demography and a higher prevalence of comorbid disorders. Owing to such circumstances, the creation of new antibiotic classes is critical.

Recent findings: Lefamulin, also referred to as BC-3781, is the primary pleuromutilin antibiotic which has been permitted for both intravenous and oral use in humans for the remedy of bacterial infections. It has shown activity against gram-positive bacteria including methicillin-resistant strains as well as atypical organisms which as often implicated in CABP. It has a completely unique mechanism of action that inhibits protein synthesis via way of means of stopping the binding of tRNA for peptide transfer. The C(14) side chain is responsible for its pharmacodynamic and antimicrobial properties, together with supporting in overcoming bacterial ribosomal resistance and mutations improvement amplifying the number of hydrogen bonds to the target site.

Summary: This review aims to highlight the pre-existing treatment options and specific purposes to shed some light upon the development of a new drug lefamulin and its specifications and explore this novel drug's superior efficacy to already existing treatment strategies.

审查目的:社区获得性细菌性肺炎(CABP)仍然是全球关注的健康问题,因为它是导致全球死亡和住院的主要原因。肺炎链球菌和其他感染病菌对大环内酯类药物耐药性的增加导致疾病负担大大增加,而人口结构的变化和合并症的增加又加剧了这一负担。在这种情况下,开发新的抗生素种类至关重要:Lefamulin 又称 BC-3781,是一种主要的胸腺嘧啶类抗生素,已获准在人体静脉注射和口服使用,用于治疗细菌感染。它对革兰氏阳性菌(包括耐甲氧西林菌株)和非典型生物体具有活性,而非典型生物体通常与 CABP 有关。它有一种完全独特的作用机制,即通过阻止 tRNA 与肽转移的结合来抑制蛋白质的合成。C(14)侧链是其药效学和抗菌特性的原因,同时还能帮助克服细菌核糖体的抗药性和突变,提高与靶点氢键的结合数量。
{"title":"Lefamulin: a New Hope in the Field of Community-Acquired Bacterial Pneumonia.","authors":"Shubham Adhikary, Meher Kaur Duggal, Saraswathy Nagendran, Meena Chintamaneni, Hardeep Singh Tuli, Ginpreet Kaur","doi":"10.1007/s40495-022-00297-6","DOIUrl":"10.1007/s40495-022-00297-6","url":null,"abstract":"<p><strong>Purpose of review: </strong>Community-acquired bacterial pneumonia (CABP) continues to be a worldwide health concern since it is the major cause of mortality and hospitalisation worldwide. Increased macrolide resistance among Streptococcus pneumoniae and other infections has resulted in a significantly larger illness burden, which has been exacerbated by evolving demography and a higher prevalence of comorbid disorders. Owing to such circumstances, the creation of new antibiotic classes is critical.</p><p><strong>Recent findings: </strong>Lefamulin, also referred to as BC-3781, is the primary pleuromutilin antibiotic which has been permitted for both intravenous and oral use in humans for the remedy of bacterial infections. It has shown activity against gram-positive bacteria including methicillin-resistant strains as well as atypical organisms which as often implicated in CABP. It has a completely unique mechanism of action that inhibits protein synthesis via way of means of stopping the binding of tRNA for peptide transfer. The C(14) side chain is responsible for its pharmacodynamic and antimicrobial properties, together with supporting in overcoming bacterial ribosomal resistance and mutations improvement amplifying the number of hydrogen bonds to the target site.</p><p><strong>Summary: </strong>This review aims to highlight the pre-existing treatment options and specific purposes to shed some light upon the development of a new drug lefamulin and its specifications and explore this novel drug's superior efficacy to already existing treatment strategies.</p>","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"8 6","pages":"418-426"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40506572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroinflammation in Epilepsy—Diagnostics and Therapeutic Perspectives 癫痫神经炎症的诊断和治疗前景
Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2021-12-08 DOI: 10.1007/s40495-021-00270-9
Piotr Lach, Wiktoria Klus, Krystian Zajdel, Adam Szeleszczuk, Ewelina Komorowska, Klaudia Burda, P. Kurowski
{"title":"Neuroinflammation in Epilepsy—Diagnostics and Therapeutic Perspectives","authors":"Piotr Lach, Wiktoria Klus, Krystian Zajdel, Adam Szeleszczuk, Ewelina Komorowska, Klaudia Burda, P. Kurowski","doi":"10.1007/s40495-021-00270-9","DOIUrl":"https://doi.org/10.1007/s40495-021-00270-9","url":null,"abstract":"","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"8 1","pages":"31 - 35"},"PeriodicalIF":0.0,"publicationDate":"2021-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45868801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Hepatic Impairment Physiologically Based Pharmacokinetic Model Development: Current Challenges 基于肝功能损害生理学的药代动力学模型开发:当前的挑战
Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2021-10-01 DOI: 10.1007/s40495-021-00266-5
Agnes Nuo Han, B. Han, Tao Zhang, T. Heimbach
{"title":"Hepatic Impairment Physiologically Based Pharmacokinetic Model Development: Current Challenges","authors":"Agnes Nuo Han, B. Han, Tao Zhang, T. Heimbach","doi":"10.1007/s40495-021-00266-5","DOIUrl":"https://doi.org/10.1007/s40495-021-00266-5","url":null,"abstract":"","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"7 1","pages":"213 - 226"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47835527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Current Pharmacology Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1